Currently, there are 53.83M common shares owned by the public and among those 42.32M shares have been available to trade.
The company’s stock has a 5-day price change of -38.11% and -68.69% over the past three months. PRTA shares are trading -66.93% year to date (YTD), with the 12-month market performance down to -78.79% lower. It has a 12-month low price of $6.36 and touched a high of $25.42 over the same period. PRTA has an average intraday trading volume of 922.13K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -38.34%, -52.75%, and -69.21% respectively.
Institutional ownership of Prothena Corporation plc (NASDAQ: PRTA) shares accounts for 83.92% of the company’s 53.83M shares outstanding.
It has a market capitalization of $246.53M and a beta (3y monthly) value of 0.05. The earnings-per-share (ttm) stands at -$2.08. Price movements for the stock have been influenced by the stock’s volatility, which stands at 16.67% over the week and 8.78% over the month.
Earnings per share for the fiscal year are expected to decrease by -60.06%, and 10.94% over the next financial year. EPS should shrink at an annualized rate of -15.31% over the next five years, compared to -3.15% over the past 5-year period.
Jefferies coverage for the Prothena Corporation plc (PRTA) stock in a research note released on May 27, 2025 offered a Hold rating with a price target of $6. Cantor Fitzgerald was of a view on May 27, 2025 that the stock is Neutral, while Chardan Capital Markets gave the stock Buy rating on December 20, 2024, issuing a price target of $40. BofA Securities on their part issued Neutral rating on January 30, 2024.
